Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Braso Maristany, F.
91  Ergebnisse:
Personensuche X
?
1

487P HER2DX ERBB2 mRNA assay following trastuzumab-based ch..:

Sauri Nadal, T. ; Pesantez Coronel, D.S. ; Braso Maristany, F....
Annals of Oncology.  35 (2024)  - p. S194 , 2024
Link: https://doi.org/10.1016/..
 
?
2

94P Biological effects of a pre-operative radiotherapy boos..:

Gomà, C. ; Brasó-Maristany, F. ; Oses, G....
ESMO Open.  9 (2024)  - p. 103165 , 2024
Link: https://doi.org/10.1016/..
 
?
3

11P Influence of ctDNA variant allele frequency (VAF) on su..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Conte, B....
ESMO Open.  9 (2024)  - p. 103020 , 2024
Link: https://doi.org/10.1016/..
 
?
4

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open.  9 (2024)  - p. 103056 , 2024
Link: https://doi.org/10.1016/..
 
?
5

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy fo..:

Angelats, L. ; Eslava, M. Santisteban ; Manich, C. Saura...
ESMO Open.  9 (2024)  - p. 103221 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Analytical validation of HER2DX genomic test for early-stag..:

Marín-Aguilera, M. ; Jares, P. ; Sanfeliu, E....
ESMO Open.  9 (2024)  3 - p. 102903 , 2024
Link: https://doi.org/10.1016/..
 
?
7

13P HER2DX ERBB2 mRNA score in first-line metastatic HER2-p..:

Bayona, R. Sanchez ; Martínez-Sáez, O. ; Romero, D.R....
ESMO Open.  9 (2024)  - p. 103022 , 2024
Link: https://doi.org/10.1016/..
 
?
8

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103017 , 2024
Link: https://doi.org/10.1016/..
 
?
9

16P Determinants of response to short preoperative endocrin..:

Bravo, R. Gómez ; Walbaum, B. ; Schettini, F....
ESMO Open.  9 (2024)  - p. 103024 , 2024
Link: https://doi.org/10.1016/..
 
?
10

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103023 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Unraveling the clinicopathological and molecular changes in..:

Schettini, F. ; Nucera, S. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  7 - p. 103619 , 2024
Link: https://doi.org/10.1016/..
 
?
12

22P Unveiling biological and prognostic differences among p..:

Walbaum, B. ; Chic, N. ; Bruñol, C. Crous...
ESMO Open.  9 (2024)  - p. 103030 , 2024
Link: https://doi.org/10.1016/..
 
?
13

1MO HER2DX assay and survival outcomes: An individual-patie..:

Javierre, G. Villacampa ; Cortés, J. ; García, J.M. Pérez...
ESMO Open.  9 (2024)  - p. 103011 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
15

136P Impact of ovarian stimulation on breast tumor biology:..:

El Gaoui, Y. Barral ; Manau, D. ; Chic, N....
ESMO Open.  9 (2024)  - p. 103123 , 2024
Link: https://doi.org/10.1016/..
 
1-15